Contractile properties of clenbuterol-treated MDX muscle are enhanced by low-intensity swimming

Journal of Applied Physiology

Volumn 82, Issue 2, 1997, Pages 435-439

  Hayes, Alan ^a   Williams, David A ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

endurance exercise; muscle fiber; muscular dystrophy; 2 agonist

Indexed keywords

ANABOLIC AGENT; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CLENBUTEROL; DYSTROPHIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EXERCISE; EXTENSOR DIGITORUM LONGUS MUSCLE; FAST MUSCLE; MALE; MOUSE; MUSCLE ATROPHY; MUSCLE CONTRACTILITY; MUSCLE DENERVATION; MUSCULAR DYSTROPHY; NONHUMAN; ORAL DRUG ADMINISTRATION; PHYSICAL STRESS; PRIORITY JOURNAL; SLOW MUSCLE; SOLEUS MUSCLE; SWIMMING;

EID: 0031051395     PISSN: 87507587     EISSN: None     Source Type: Journal    
DOI: 10.1152/jappl.1997.82.2.435     Document Type: Article

References (28)

1. Agbenyega, E. T., and A. C. Wareham. Effect of clenbuterol on normal and denervated muscle growth and contractility. Muscle Nerve 13: 199-203, 1990.
2. Anderson, J. E., B. H. Bressler, and W. K. Ovalle. Functional regeneration in the hindlimb skeletal muscle of the mdx mouse. J. Muscle Res. Cell Motil. 9: 499-515, 1988.
3. Babij, P., and F. W. Booth. Clenbuterol prevents or inhibits loss of specific mRNAs in atrophying rat skeletal muscle. Am. J. Physiol. 254 (Cell Physiol. 23): C657-C660, 1988.
4. Baker, P. K., R. H. Dalrymple, D. L. Ingle, and C. A. Ricks. Use of a β-adrenergic agonist to alter muscle and fat deposition in lambs. J. Anim. Sci. 59: 1256-1261, 1984.
5. 2+ levels in myotubes grown from the skeletal muscle of dystrophic (mdx) and normal mice. J. Physiol. Lond. 460: 1-13, 1993.
6. Bodensteiner, J. B., and A. G. Engel. Intracellular calcium accumulation in Duchenne dystrophy and other myopathies: a study of 567,000 muscle fibers in 114 biopsies. Neurology 28: 439-445, 1978.
7. Bowman, W. C. Effects of adrenergic activators and inhibitors on the skeletal muscles. In: Handbook of Experimental Pharmacology, edited by L. Szekeres. Berlin: Springer Verlag, 1980, vol. 54, sect. II, p. 47-128.
8. Bulfield, G., W. G. Siller, P. A. L. Wight, and K. J. Moore. X chromosome-linked muscular dystrophy (mdx) in the mouse. Proc. Natl. Acad. Sci. USA 81: 1189-1192, 1984.
9. Dupont-Versteegdon, E. E., R. J. McCarter, and M. S. Katz. Voluntary exercise decreases progression of muscular dystrophy in diaphragm of mdx mice. J. Appl. Physiol. 77: 1736-1741, 1994.
10. 2-adrenergic agonists on body composition and protein synthesis in the rat. Biosci. Rep. 4: 83-91, 1984.
11. Hayes, A., G. S. Lynch, and D. A. Williams. The effects of endurance exercise on dystrophic mdx mice. I. Contractile and histochemical properties of intact muscles. Proc. R. Soc. Lond. Biol. Sci. 253: 19-25, 1993.
12. Hayes, A., and D. A. Williams. Long-term clenbuterol administration alters the isometric contractile properties of skeletal muscle from normal and dystrophin-deficient mdx mice. Clin. Exp. Pharm. Physiol. 21: 757-765, 1994.
13. Hayes, A., and D. A. Williams. Beneficial effects of voluntary wheel running on the properties of dystrophic mouse muscle. J. Appl. Physiol. 80: 670-679, 1996.
14. Hoffman, E. P., R. H. Brown, Jr., and L. M. Kunkel. Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell 51: 919-928, 1987.
15. Karpati, G., S. Carpenter, and S. Prescott. Small-caliber skeletal muscle fibers do not suffer necrosis in mdx mouse dystrophy. Muscle Nerve 11: 795-803, 1988.
16. Kim, Y. S., and R. D. Sainz. β-Adrenergic agonists and hypertrophy of skeletal muscles. Life Sci. 50: 397-407, 1992.
17. Maltin, C. A., M. I. Delday, S. M. Hay, and A. G. S. Baillie. Denervation increases clenbuterol sensitivity in muscle from young rats. Muscle Nerve 14: 188-192, 1992.
18. Maltin, C. A., M. I. Delday, J. S. Watson, S. D. Heys, I. M. Nevison, I. K. Ritchie, and P. H. Gibson. Clenbuterol, a β-adrenoceptor agonist, increases relative muscle strength in orthopaedic patients. Clin. Sci. Lond. 84: 651-654, 1993.
19. Ogilvie, R. W., and D. L. Feeback. A metachromatic dye-ATPase method for the simultaneous identification of skeletal muscle fiber types I, IIa, IIb, and IIc. Stain Tech 65: 231-241, 1990.
20. Pastoret, C., and A. Sebille. Time course study of the isometric contractile properties of mdx mouse striated muscles. J. Muscle Res. Cell Motil. 14: 423-431, 1993.
21. Reeds, P. J., S. M. Hay, P. M. Dorwood, and R. M. Palmer. Stimulation of muscle growth by clenbuterol: lack of effect on muscle protein biosynthesis. Br. J. Nutr. 56: 249-258, 1986.
22. Ricks, C. A., R. H. Dalrymple, P. K. Baker, and D. L. Ingle. Use of a β-agonist to alter fat and muscle deposition in steers. J. Anim. Sci. 59: 1247-1255, 1984.
23. Wakeford, S., D. J. Watt, and T. A. Partridge. X-irradiation improves mdx mouse muscle as a model of myofiber loss in DMD. Muscle Nerve 14: 42-50, 1991.
24. Webster, C., L. Silberstein, A. P. Hays, and H. M. Blau. Fast muscle fibers are preferentially affected in Duchenne muscular dystrophy. Cell 52: 503-513, 1988.
25. Williams, D. A., S. I. Head, A. J. Bakker, and D. G. Stephenson. Resting calcium concentrations in isolated skeletal muscle fibers of dystrophic mice. J. Physiol. Lond. 428: 243-256, 1990.
26. 2-receptor agonist. Am. J. Physiol. 254 (Endocrinol. Metab. 17): E726-E732, 1988.
27. 2-agonist, retards atrophy in denervated muscles. Am. J. Physiol. 252 (Endocrinol. Metab. 15): E152-E155, 1987.
28. 2-agonist, retards wasting and loss of contractility in irradiated dystrophic mdx muscle. Am. J. Physiol. 267 (Cell Physiol. 36): C865-C868, 1994.